Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-000780
Filing Date
2024-01-03
Accepted
2024-01-03 16:05:49
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2151
  Complete submission text file 0001213900-24-000780.txt   3798
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Issuer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ONCONETIX, INC. 201 E. FIFTH STREET, SUITE 1900 CINCINNATI OH 45202
Business Address
Schiess Ralph (Reporting) CIK: 0002006201 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41294 | Film No.: 24506304